ERBB2 and breast neoplasm: A NP-neu can mark early breast tumors and remarkably, just a NP-neu bound to the automatical lung, liver, and bone marrow metastases in a transgenic mouse pattern of MBC, highlighting the urgency of targeting for a delivery to metastatic disease.